Y200-2115 Screening compound: N-[6-(3,4-dimethoxybenzamido)pyridin-2-yl]-3,4-dimethoxybenzamide

Y200-2115 Screening compound: N-[6-(3,4-dimethoxybenzamido)pyridin-2-yl]-3,4-dimethoxybenzamide
Y200-2115 Screening compound: N-[6-(3,4-dimethoxybenzamido)pyridin-2-yl]-3,4-dimethoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-2115
N-[6-(3,4-dimethoxybenzamido)pyridin-2-yl]-3,4-dimethoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-2115

Molecular Formula

C23H23N3O6 (C23 H23 N3 O6)

Compound Name

N-[6-(3,4-dimethoxybenzamido)pyridin-2-yl]-3,4-dimethoxybenzamide

IUPAC name

N-[6-(34-dimethoxybenzamido)pyridin-2-yl]-34-dimethoxybenzamide

SMILES

COc(ccc(C(Nc1cccc(NC(c(cc2)cc(OC)c2OC)=O)n1)=O)c1)c1OC

InChI

InChI=1S/C23H23N3O6/c1-29-16-10-8-14(12-18(16)31-3)22(27)25-20-6-5-7-21(24-20)26-23(28)15-9-11-17(30-2)19(13-15)32-4/h5-13H,1-4H3,(H2,24,25,26,27,28)

InChI Key

OBXGFAOTEHBATK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00993084

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.45

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.393

Distribution Coefficient, logD

3.392

Water Solubility, LogSw

-3.79

Polar Surface Area

86.692

Acid Dissociation Constant (pKa)

9.74

Base Dissociation Constant (pKb)

1.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.40

Y200-2115 in Drug Discovery

Included in Screening Libraries

Autophagy-Targeted Library (4564 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Proteases
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with Y200-2115 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-2115?
Check Price and Availability of Y200-2115, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-2115 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-2115
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-2115
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-2115 available by request